Looking forward, several new GLP-1 medicines are being developed and will likely be released in combination with another medicine, Drucker said
The risks fall into three buckets Common, mild, self-limiting Bruising or soreness at the catheter site Cool sensation along the arm during the drip Warm flush or metallic taste, especially with magnesium or B-complex Mild lightheadedness if the drip runs too fast Uncommon Phlebitis, or vein irritation, especially with stronger or more concentrated formulas Infiltration (fluid leaking under the skin if the catheter shifts) Allergic reactions to specific ingredients, particularly thiamine and B-complex Rare but serious Infection at the IV site Fluid overload in patients with heart, kidney, or liver disease Electrolyte disturbances, especially with high-dose magnesium, potassium, or calcium Red blood cell problems in people with G6PD deficiency, a genetic enzyme issue
Cell receptors help stimulate biological responses
Additionally, do not self-inject unless your prescriber explicitly trained and instructed you to do so
Khan I, Elhissi A, Shah M, Alhnan MA, Ahmed W
Their initial recommendation: DO NOT add BPC-157 to the 503A Bulks List
